What is Bio-Technology Profit Alliance?
Bio-Technology Profit Alliance is a new high-end biotech service from Michael Robinson, who also edits the tech and biotech-focused Nexus-9 Network, Nova-X Report and Radical Technology Profits newsletters. Launched during the biotech boom caused by the COVID-19 pandemic, aims to produce a new recommendation every week, and focus on world-changing biotech innovations.
The fact that governments and corporations around the world are pouring tens of billions of dollars into the biotech sector right now points to one major trend. And it’s not just that governments and every major global leader are trying to stop the spread of Covid-19.
That’s only part of it; the bigger picture is much, much bigger.
Though the fact that the E.U. has raised $8 billion and the Trump Administration initiated Operation Warp Speed, funding research and development with billions of dollars, does give us a hint.
In short, we’re experiencing a new era: a biotech revolution.
That’s why Michael Robinson and his team have created a one-of-a-kind research service: the Bio-Technology Profit Alliance.
With the global biotech sector projected to grow to over $720 billion in the next five years, medical breakthroughs that once took years to develop are moving at record speed. And that means we could see highly lucrative seed-level plays come fast and furious.
Being on the right side of these technologies will give you a shot to make 10, times your money over the next few years.
- A revolutionary “skinny pill” that could make obesity a thing of the past.
- A life-saving rescue pen for diabetics.
- An artificial intelligence technology that can detect kidney disease simply by combing electronic patient databases.
- Smart contact lenses that treat glaucoma, diabetic retinopathy, vein occlusion, and a number of other eye conditions that currently require intensive use of eye drops or in-office injections.
- And get this: a surgically implanted memory chip that reverses memory loss from stroke and Alzheimer’s.
Michael Robinson’s goal was not just another research service with the Bio-Technology Profit Alliance. He wants you in front of every profit opportunity he’ll see in the coming years. That’s why the Alliance is a full-immersion experience.
— RECOMMENDED —
Want the chance to put $2,500, $5,000, $10,000, or more in your pocket every Thursday?
Breakthrough “Super Vaccine” Slated for Production: What’s being touted in latest teaser for Michael Robinson’s Bio-Technology Profit Alliance?
A game-changing breakthrough Michael Robinson calls the “Super Vaccine” is now starting production.
In trials, it has already generated an immune response in humans, and the FDA has granted it a Fast-Track Designation.
The administration has infused the company with $483 million to expedite approval.
And now, not only has a contract for 10 billion doses been signed… but production is now underway for the viable “Super Vaccine!”
Bottom line: Not only could the “Super Vaccine” bring COVID-19 to its knees, it could also ignite a staggering 58,300% revenue surge for one tiny $60 million company.
In his presentation Michael Robinson explaines, the tiny $60 million company behind the super vaccine is poised for a 58,300% revenue surge. And he believes there are several reasons why:
- The super vaccine has already generated an immune response in humans.
- The FDA granted approval in a record 43 days for Phase 1.
- The company is so confident FINAL APPROVAL is a matter of formality that they’ve signed a contract to produce 10 billion doses, with one billion to be produced in the coming year alone.
It’s really no surprise. After all, the tiny $60 million company behind that vaccine has some advantages that have allowed it to leap forward at an astounding pace.
The presidential administration’s vaccine czar sat on the company’s board and was holding $10 million in stock options the day of his appointment.
At the same time, Trump’s FDA granted this tiny company a Fast-Track Designation and infused the company with $483 million to expedite approval.
Again, this could set up a 58,300% revenue surge, and that’s if only one-tenth of the contract is fulfilled!
To get all the information about this company, investors have to sign up for Michael Robinson’s Bio-Technology Profit Alliance research.
Time is of the essence, and that’s why it’s critical to take advantage of the Bio-Technology Profit Alliance.
Slots in this new research service are limited, and considering that premier members can get an instant $3,000 credit… it needs your serious consideration.
And remember, this is only the beginning for this tiny company Michael Robinson is advocating today.
The super vaccine’s platform is universal in nature. That means it could be used to stop future pandemics BEFORE they even begin.
At the same time, the super vaccine’s platform could usher in a WHOLE NEW CLASS of drugs that completely disrupts the $3.2 trillion health-care industry. And with 100 patents protecting their proprietary property, they could be positioned to dominate in a big way.
In fact, they’re already working on a personalized cancer vaccine. A heart drug that can regrow blood vessels destroyed during heart attacks. Plus, they’re working on breakthrough vaccines to combat everything from hepatitis to the flu and beyond.
But again, time is of the essence…
Production on the super vaccine is planned to begin, and the company is poised for a 58,300% revenue surge in the coming year alone.
If you are one of the first 447 folks who subscribe today, you can take advantage of the $3,000 instant credit. The great part is you can use that $3,000 savings to jump on the super vaccine company or in any way you wish.
— RECOMMENDED —
GET FREE 3-day Video Trading Series Showing You How to Start Making an Extra $1,000 a Month.
What’s Included With Your Bio-Technology Profit Alliance Subscription?
By subscribing to Michael Robinson’s Bio-Technology Profit Alliance, you’ll get immediate online access to a Special Insider Dossier containing everything you need to know about the super vaccine company.
And it gets better…
As a new member of the Bio-Technology Profit Alliance, you’ll get a constant flow of incredible recommendations, each with the potential to make you fabulously wealthy, including:
Biotech Revolution Play #2: The Vaccine Manufacturer!
To inoculate the world against COVID-19, you need to manufacture the vaccines. That ’s why the super vaccine company signed a 10 billion-dose contract. But instead of dividing those doses up among a handful of manufacturers located around the world, they handed that 10 billion-dose deal to one company. They plan to start production imminently. And they don’t plan on stopping until 10 billion doses hit the market. They’ve developed a state-of-the-art facility built on a former U.S. Air Force base so they can produce billions of vaccines and whip them around the world with a moment’s notice. In addition, they are located in what’s called a Foreign-Trade Zone, giving them a tremendous competitive advantage against other manufacturers. And with over 2,300 patents protecting its proprietary manufacturing processes, this company could surge 10-fold in the coming year.
Biotech Revolution Play #3: The COVID-19 Test!
Testing is critical to opening the economy full-steam ahead. And this company has developed a finger-stick test. Very simple. And blazing fast. It takes as little as 10 minutes to get results. Even better, the accuracy is virtually unprecedented: A 100% specificity, which means you practically don’t get any false negatives. Plus, the company’s analyzers can conduct 440 tests per hour. So a single testing center could conduct 10,560 tests a day. The company shipped over one million tests this month and is ramping up production to 50 million tests per month. The tests only run $5 a pop. So they are literally available to anyone in the world. Even at that low price, this company could see a $250 million monthly revenue surge starting now and potentially continuing for years. The FDA has already granted Emergency Use Authorization, and we project a possible 10-fold win in the coming 18 months!
Biotech Revolution Play #4: Insulin for 7.5 Million Americans!
In landmark legislation, the FDA changed insulin’s designation from drug to biological product. This allows for biosimilar insulin to enter the market with guns blazing. With 7.5 million Americans relying on insulin for survival, the market is screaming to be disrupted. And one company is ready to do it. Their new drug is expected to be priced at 80% less than the industry leader. Even if they capture a mere 15% of the market, this company would see an estimated $5.5 billion in new revenue. Michael Robinson is looking at potentially a triple in the next 12 months.
Biotech Revolution Play #5: Teledentistry!
When Invisalign disrupted the orthodontics market, its stock surged a rare and extraordinary 22,000% over two decades. This newest disruption could be even bigger. Because the company makes impression kits, patients can fix their crooked teeth WITHOUT an office visit! All they need to do is bite down and then mail the model back in a postage-paid carton. The great part is this company can get the job done at a fraction of the cost of competitors – just $85 a month. They already control 90% of this niche market and have a patent to protect their business for many years to come. With 5.8 billion people around the globe suffering from misaligned teeth, this could be an astronomical home run that delivers a potential 10-fold win in the next two years!
Every single one of these plays is ready to move NOW. And the moment you agree to give Bio-Technology Profit Alliance a try, you’ll get instant online access to Special Insider Dossiers detailing each of these extraordinary plays.
And these plays are still just the beginning…
We are in a whole new era. Medical breakthroughs that once took years to develop are moving at record speed. And that means we could see highly lucrative seed-level plays come fast and furious. Right now, Michael Robinson is tracking medical innovations with world-changing potential. Here are just a few from Michael’s current watch list.
Watch-List Play #1: A revolutionary “skinny pill” that could make obesity a thing of the past!
Watch-List Play #2: A life-saving rescue pen for diabetics!
Watch-List Play #3: An artificial intelligence technology that can detect kidney disease early!
Watch-List Play #4: Smart contact lenses that treat glaucoma, diabetic retinopathy, and a number of other eye conditions that currently require in-office injections!
Watch-List Play #5: A surgically-implanted memory chip that reverses memory loss from stroke and Alzheimer’s!
These plays are still in early stages and aren’t yet ready to hit. But when the time is right, Michael Robinson will let subscribing members know how to pull the trigger for maximum potential upside.
Of course, the Bio-Technology Profit Alliance is more than just a research service; it’s a full-immersion experience. An unprecedented opportunity for folks to witness the full transformative power of the biotech revolution up close and personal.
Let me summarize all your member benefits:
Special Insider Dossiers
These reports are packed with detailed information on all the plays we discussed today. Plus, you’ll get a new recommendation every week! That’s 50 plays in the first year alone, each with extraordinary potential to double, triple, or even show 10X returns in the next 12 months!
Scientific Video Briefings
With over 25 years of experience in the healthcare and pharmaceutical industries, Michael Robinson’s team of scientific experts have a knack for breaking down complex scientific concepts and making them simple and easy to understand. And they’re going to show folks exactly how these world-changing innovations work. That means people can really become experts in the technologies they’re investing in!
This is Michael Robinson and his team exclusive, online, members-only forum where you can join other subscribing members to share ideas, talk about the latest technologies, exchange investment strategies, and even pick up special insights about new and emerging opportunities. A real community!
Weekly Market Updates
You’ll never be left wondering what’s up with any stock Michael Robinson is recommending. Every day, he’s in touch with medical experts, on the phone with scientists, and talking with company officials – so you’ll know everything relevant to the stock’s success.
Michael Robinson and his team constantly monitor each and every play closely. And when the time is right, members will receive a Real-Time Profit Alert telling them exactly how to take any profits.
Insider Field Reports
Michael Robinson is constantly on the go, traveling around the world, meeting with CEOs and industry insiders. When he uncovers breaking news, you’ll be among the first to know. In fact, he will take out his phone and film Insider Field Reports. He will be shooting at the facilities he’s touring. These videos will be raw, and will include down-and-dirty research with an insider’s twist. It’s information that you can only get when you have boots on the ground. One of a kind!
Monthly Executive Roundtables
These cutting-edge gatherings will feature company board members, as well as founders of major biotech firms. You’ll get to watch me grill them for exclusive insight and breaking developments. A must for anyone interested in learning how to secure a ground-floor edge!
As you can see, the Bio-Technology Profit Alliance is unlike any research service on the planet. Members will be able to take a deep dive into revolutionary technologies poised to transform the world.
Each and every play has the potential to deliver life-changing gains and give folks a shot at 10, 25, even as high as 50 times their money within the next 18 months when we really hit the jackpot.
— RECOMMENDED —
Thousands of Americans have been hit by a wave of wealth in the wake of COVID-19. Stocks are up 40% since the crash, yet some lucky retirees have the opportunity to see 100%+ gains because of what’s coming next. How are they doing it?
For the first time in history, two millionaire investors have joined forces to help you learn the secret moneymaking strategy of the wealthy and connected.
As of moment of writing a full-year subscription to Bio-Technology Profit Alliance is available for $1,950.
Is there any Guarantee?
Yes. Michael Robinson calls it: 10X Pledge & Money-Back Guarantee
As a charter member of Bio-Technology Profit Alliance, the plays are going to come fast and furious. In any given week, you could see a play that could give you a shot at as much as 100%, 200%, 500%, even as much as 10 times your money over the next 18 months.
With that in mind, if your track record doesn’t show at least 50 of these opportunities in the next 12 months, all you have to do is call Michael Robinson’s team, and they will refund every penny of your subscription price. No questions asked.
Meet Michael Robinson
Michael Robinson, the founder of the Bio-Technology Profit Alliance is one of the gurus behind Money Map Press. These guys are committed to bringing the best financial research to their members. Robinson has three and a half decades experience within Silicon Valley, and he’s one of the top technological financial analysts around today.
This is THE go-to guy for the Silicon Valley venture capital firms, and he enjoys privileged accessed to high profile industry insiders, CEOs, and cutting edge scientists.
He’s also a regular on CNBC and Fox Business, as well as being a Pulitzer nominated writer and reporter. It’s certainly safe to say that this is a guy who certainly knows his stuff…
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse – years before the word “bailout” became a household word.
Silicon Valley defense publications vie for his analysis. He’s worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
— RECOMMENDED —
You could have massive overnight gains throughout this entire crisis.
“Blitz Tracker” shrinks your exposure by controlling your time spent in the market and regularly delivers powerful 24-hour gains.
Uncle Sam promised a vaccine by Election Day.
And today, nearly six months after the first confirmed case on U.S. soil, this may be the rest of the story behind that promise. You see, production is now underway for a new breakthrough we call the “Super Vaccine.”
Already, in trials this viable response to COVID-19 has generated positive results in humans.
Now, here’s the kicker:
The FDA has granted the firm behind the vaccine a Fast-Track Designation. Sure, this isn’t the ONLY biotech firm out there vying for immunization. But they’re the only one the administration has infused with $483 million.
And the surge doesn’t stop there.
Right now, one billion doses are being fast-tracked.
And that’s just the beginning of a massive production effort. Now, when all is said and done – the “Super Vaccine” could bring COVID-19 to its knees…
And it could also spark a staggering 58,300% revenue surge for one tiny company.